These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36463780)

  • 1. Effect of Implanted Defibrillator on Mortality in Patients With Chronic Kidney Disease.
    Al-Sadawi M; Aslam F; Tao M; Ijaz H; Alsaiqali M; Fan R; Rashba EJ
    Am J Cardiol; 2023 Feb; 188():36-40. PubMed ID: 36463780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated Glomerular Filtration Rate and Implantable Cardioverter-Defibrillator in Nonischemic Systolic Heart Failure: Extended Follow-Up of DANISH.
    Doi SN; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Yafasova A; Bruun NE; Gustafsson F; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Butt JH
    J Am Heart Assoc; 2024 Feb; 13(3):e031977. PubMed ID: 38293926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.
    Makki N; Swaminathan PD; Hanmer J; Olshansky B
    Europace; 2014 Jan; 16(1):55-62. PubMed ID: 24058182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Implantable Cardioverter Defibrillators Reduce Mortality in Patients With Chronic Kidney Disease at All Stages?
    Fu L; Zhou Q; Zhu W; Lin H; Ding Y; Shen Y; Hu J; Hong K
    Int Heart J; 2017 May; 58(3):371-377. PubMed ID: 28539571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease.
    Bansal N; Szpiro A; Reynolds K; Smith DH; Magid DJ; Gurwitz JH; Masoudi F; Greenlee RT; Tabada GH; Sung SH; Dighe A; Go AS
    JAMA Intern Med; 2018 Mar; 178(3):390-398. PubMed ID: 29404570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.
    Pun PH; Hellkamp AS; Sanders GD; Middleton JP; Hammill SC; Al-Khalidi HR; Curtis LH; Fonarow GC; Al-Khatib SM
    Nephrol Dial Transplant; 2015 May; 30(5):829-35. PubMed ID: 25404241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator.
    Hoffmeister JM; Estes NA; Garlitski AC
    J Interv Card Electrophysiol; 2012 Nov; 35(2):227-34. PubMed ID: 22956011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.
    Hess PL; Hellkamp AS; Peterson ED; Sanders GD; Al-Khalidi HR; Curtis LH; Hammill BG; Pun PH; Curtis JP; Anstrom KJ; Hammill SC; Al-Khatib SM
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):793-9. PubMed ID: 25038119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of death without appropriate defibrillator shock in patients with advanced renal dysfunction.
    Goldenberg I; Mor T; Nof E; Younis A; Berkovitch A; Rosso R; Barsheshet A; Suleiman M; Beinart R
    Europace; 2019 Mar; 21(3):459-464. PubMed ID: 30689821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.
    Pun PH; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton AE; Moss AJ; Lee KL; Steinman R; Dorian P; Hallstrom A; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Hess PL; Inoue LY; Sanders GD
    Am J Kidney Dis; 2014 Jul; 64(1):32-9. PubMed ID: 24518128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes in Patients with Severe Renal Dysfunction Including Dialysis Following Defibrillator Implantation.
    Bogdan S; Nof E; Eisen A; Sela R; Rosenheck S; Freedberg N; Geist M; Ben-Zvi S; Haim M; Glikson M; Goldenberg I; Suleiman M;
    Am J Nephrol; 2015; 42(4):295-304. PubMed ID: 26529418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
    El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients.
    Shurrab M; Ko DT; Zayed Y; Navaneethan SD; Yadak N; Yaseen A; Kaoutskaia A; Qamhia W; Hamdan Z; Haj-Yahia S; Lee DS; Newman D; Healey JS; Harvey P; Crystal E
    J Interv Card Electrophysiol; 2018 Oct; 53(1):123-129. PubMed ID: 30058056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of patients with chronic kidney disease and implantable cardiac defibrillator: primary versus secondary prevention.
    Hage FG; Aljaroudi W; Aggarwal H; Bhatia V; Miller J; Doppalapudi H; Wazni O; Iskandrian AE
    Int J Cardiol; 2013 Apr; 165(1):113-6. PubMed ID: 21862150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Bansal N; Szpiro A; Masoudi F; Greenlee RT; Smith DH; Magid DJ; Gurwitz JH; Reynolds K; Tabada GH; Sung SH; Dighe A; Cassidy-Bushrow A; Garcia-Montilla R; Hammill S; Hayes J; Kadish A; Sharma P; Varosy P; Vidaillet H; Go AS
    Heart; 2017 Apr; 103(7):529-537. PubMed ID: 27742796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators.
    Seegers J; Conen D; Jung K; Bergau L; Dorenkamp M; Lüthje L; Sohns C; Sossalla ST; Fischer TH; Hasenfuss G; Friede T; Zabel M
    Europace; 2016 Aug; 18(8):1194-202. PubMed ID: 26622054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable Cardioverter Defibrillators and Chronic Kidney Disease.
    Kiage JN; Latif Z; Craig MA; Mansour N; Khouzam RN
    Curr Probl Cardiol; 2021 Mar; 46(3):100639. PubMed ID: 32624194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.
    Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ;
    Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.